Prostate Cancer Testing in Elderly Men: New Approach and Considerations

Elderly men commonly suffer from both lower urinary tract symptoms (LUTS) and a high likelihood of indolent prostate cancer (PCa). A new study from Brown University Warren Alpert Medical School addresses the challenges of evaluating these patients and balancing the objectives of detecting potentially dangerous disease while avoiding over-testing and overdiagnosis. Researchers propose a three-tiered approach to evaluating patients with LUTS to better assess PCa risk.

Key Takeaways:

• The study emphasizes the importance of understanding the relationship between LUTS and PCa risk in elderly men, as LUTS may lead to a cascade of testing and possible overdiagnosis.
• A literature review of 2023 publications revealed that PCa risk assessment tools, including PSA permutations, novel biomarkers, and imaging, have limitations in older men.
• The proposed three-tiered approach involves evaluating patients with LUTS to assess PCa risk, considering both the patient's and provider's perspectives.
• The study highlights the need for a shared decision-making approach to balance the objectives of detecting phenotypically dangerous disease and avoiding over-testing and overdiagnosis.

Statistics:

• 2023 publications were reviewed for the study, providing a comprehensive overview of current knowledge on PCa risk assessment in elderly men.
• 69% of elderly men experience LUTS, which may lead to overdiagnosis and unnecessary treatment.
• Prostate cancer affects approximately 1 in 9 men, with the majority being diagnosed at an older age.

Sources:

• "Lower urinary tract symptoms in elderly men: Considerations for prostate cancer testing," The Prostate, 2024, Wiley.
• https://doi-org.sdpl.idm.oclc.org/10.1002/pros.24772 (free article available).
• Stephen Schmit et al., Brown University Warren Alpert Medical School, 2024.